injection of CCK reduces food intake and triggers a behavioral pattern similar to natural satiation. Reduction of food intake by CCK is mediated by vagal afferents that innervate the stomach and small intestine. These afferents synapse in the hindbrain nucleus of the solitary tract (NTS) where gastrointestinal satiation signals are processed. Previously, we demonstrated that intraperitoneal (IP) administration of either competitive or noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists attenuates reduction of food intake by CCK. However, because vagal afferents themselves express NMDA receptors at both central and peripheral endings, our results did not speak to the question of whether NMDA receptors in the brain play an essential role in reduction of feeding by CCK. We hypothesized that activation of NMDA receptors in the NTS is necessary for reduction of food intake by CCK. To test this hypothesis, we measured food intake following IP CCK, subsequent to NMDA receptor antagonist injections into the fourth ventricle, directly into the NTS or subcutaneously. We found that either fourth-ventricle or NTS injection of the noncompetitive NMDA receptor antagonist MK-801 was sufficient to inhibit CCK-induced reduction of feeding, while the same antagonist doses injected subcutaneously did not. Similarly fourth ventricle injection of D-3-(2-carboxypiperazin-4-yl)-1-propenyl-1-phosphoric acid (D-CPPene), a competitive NMDA receptor antagonist, also blocked reduction of food intake following IP CCK. Finally, DCPPene injected into the fourth ventricle attenuated CCK-induced expression of nuclear c-Fos immunoreactivity in the dorsal vagal complex. We conclude that activation of NMDA receptors in the hindbrain is necessary for the reduction of food intake by CCK. Hindbrain NMDA receptors could comprise a critical avenue for control and modulation of satiation signals to influence food intake and energy balance.vagus; satiation; gut-brain peptides SATIATION IS THE PROCESS by which food entering the gastrointestinal tract gradually reduces food intake, eventually resulting in termination of a meal. Previous reports from our group and others indicate that systemic administration of antagonists of N-methyl-D-aspartate-type glutamate receptors (NMDAr antagonists) delays satiation and increases meal size (see, for example, Refs. 8, 9, and 25). Additionally, we demonstrated that injecting NMDAr antagonists directly into the nucleus of the solitary tract (NTS), where vagal afferents from the gastrointestinal tract synapse, increases meal size (19,23,46) and that lesions of the NTS abolish this effect (47). These observations suggest that NMDA receptors, perhaps in the NTS, participate in vagally mediated control of food intake.The hypothesis that NMDA receptors participate in the process of satiation is supported by our prior reports that peripherally administered NMDA receptor antagonists attenuate reduction of food intake induced by CCK (11, 19), a gut peptide known to reduce food intake by activating abdominal vagal a...